Quick Answer
CLOVER HEALTH INVESTMENTS, CORP. /DE reported Net Income Loss of -$85.55 million for the year ending 2025.
- CLOVER HEALTH INVESTMENTS, CORP. /DE showed a decrease of -98.9% in Net Income Loss from 2024 to 2025.
- This data is from CLOVER HEALTH INVESTMENTS, CORP. /DE's annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2019: -$17.6 thousand | Q1 2020: -$28.16 million | Q2 2020: $5.40 million | Q3 2020: $12.76 million | Q1 2021: -$48.42 million | Q2 2021: -$317.61 million | Q3 2021: -$34.53 million | Q1 2022: -$75.49 million | Q2 2022: -$104.36 million | Q3 2022: -$75.49 million | Q1 2023: -$72.61 million | Q2 2023: -$28.81 million | Q3 2023: -$41.47 million | Q1 2024: -$19.17 million | Q2 2024: $7.41 million | Q3 2024: -$9.16 million | Q1 2025: -$1.27 million | Q2 2025: -$10.58 million | Q3 2025: -$24.38 million.
- Over the full 7 years of available data (2019 to 2025), CLOVER HEALTH INVESTMENTS, CORP. /DE's Net Income Loss has grown by 76.5%.
- Historical annual values: Fiscal year 2025: -$85.55 million | Fiscal year 2024: -$43.01 million | Fiscal year 2023: -$213.36 million | Fiscal year 2022: -$339.57 million | Fiscal year 2021: -$587.76 million | Fiscal year 2020: -$136.39 million | Fiscal year 2019: -$363.74 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: